Siddharth Kaul
Direktor/Vorstandsmitglied bei IMMUNOCORE HOLDINGS PLC
Vermögen: - $ am 30.04.2024
Profil
Siddharth Kaul is currently serving as the Director at Helsinn Healthcare SA since 2022.
He is also an Independent Non-Executive Director at Immunocore Holdings Plc since 2022.
Additionally, Mr. Kaul holds the position of Non-Executive Director at Immunocore Ltd.
Mr. Kaul previously worked as the Chief Financial Officer-Pharma Europe at Novartis AG in 2021.
He holds an MBA from Indiana University and an undergraduate degree from West Virginia University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 02.01.2024 | 0 ( nan% ) | - $ | 30.04.2024 |
Aktive Positionen von Siddharth Kaul
| Unternehmen | Position | Beginn |
|---|---|---|
| IMMUNOCORE HOLDINGS PLC | Direktor/Vorstandsmitglied | 08.06.2022 |
Helsinn Healthcare SA
 Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Direktor/Vorstandsmitglied | 15.01.2022 |
Immunocore Ltd.
 Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Siddharth Kaul
| Unternehmen | Position | Ende |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01.04.2021 |
Ausbildung von Siddharth Kaul
| West Virginia University | Undergraduate Degree |
| Indiana University | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| IMMUNOCORE HOLDINGS PLC | Health Technology |
| NOVARTIS AG | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Health Technology |
Immunocore Ltd.
Immunocore Ltd. Pharmaceuticals: MajorHealth Technology Part of Immunocore Holdings Plc, Immunocore Ltd. is a British commercial-stage biotechnology company that develops and commercializes transformative medicines to address unmet needs in cancer, infection, and autoimmune disease. The company is based in Oxon, UK. The company has a robust pipeline of wholly owned and partnered programs to address a broad spectrum of disease indications, built on their proprietary soluble TCR bi-specific Immtac® platform. The company was founded in 2007, and the CEO is Bahija Jallal. | Health Technology |
